Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Benzer Materyaller

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  Yazar:: Mukhtyar, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  Yazar:: Mukhtyar, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  Yazar:: Saket Jha, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  Yazar:: Zhi-Ying Li, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-08-01)
• Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
  Yazar:: Moog P, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-11-01)